The microbial gene editing services market is projected to grow from USD 9.0 billion in 2025 to USD 51.3 billion by 2035, at a CAGR of 19.0%. Microbial CRISPR/Cas9 Genes will dominate with a 38.7% market share, while pharmaceutical applications will lead the application segment with a 42.1% share.